News and Comments

Halozyme's PEGPH20 Trial Results Are Worth Appreciating Not Doubting

  Friday, January 06, 2017

Extremely important, not just exciting, were the results of Halozyme Therapeutics’s (HALO) Phase 2 randomized, multi-center clinical trial of its PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine in stage IV pancreas cancer.  More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

C4 Therapeutics Illumina (ILMN) PTC Therapeutics (PTCT) Advaxis (ADXS) Intercept (ICPT) Mirati Therapeutics (MRTX) Trastuzumab-DM1 Exelixis (EXEL) Benlysta (belimumab) OSI (OSIP) HALOZYME (HALO) Sarepta (SRPT) Rapamune Herceptin Prosensa (RNA) Sangamo (SGMO) GUARDIAN HEALTH Human Genome Sciences (HGSI) ARGOS (ARGS) Endometrial Cancer Sequenom (SQNM) Idenix (IDIX) CRISPR Therapeutics (CRSP) MODERNA Gilead (GILD) AstraZeneca (AZN) Editas (EDIT) Aimmune Therapeutics (AIMT) Genentech Anadys (ANDS) ACADIA (ACAD) Amgen (AMGN) CompuGen (CGEN) Onyx (ONXX) ABBVIE (ABBV) AGOS (ARGS) VANDA (VNDA) Theravance Bio Pharma (TBPH) Incyte (INCY) NANTKWEST (NK) Revlimid (lenolidamide) NEKTAR (NKTR)) Alnylam (ALNY) SERES THERAPEUTICS (MCRB) LEXICON (LXRX) Galena (GALE) ImmunoGen (IMGN) Multiple Myeloma Spike Therapeutics (ONCE) Micromet (MITI) Sanofi-Aventis (SAN) Dendreon (DNDN) ADVENTRIX (ANX) ARCA (ABIO) BIOMARIN (BMRN) Valeant Pharmaceuticals International (VRX) galapagos (GLPG) Intermune (ITMN) Bristol-Myers Squibb (BMY) NOVOCURE (NVCR) TOKAI (TKAOI) Jazz Pharmaceuticals (JAZZ) Array Pharmaceuticals (ARRY) Telaprevir Seattle Genetics (SGEN) ZALTRAP™ Ariad (ARIA) Sanofi (SNA) Biocryst (BCRX) Cytokinetics (CYTK) Pluristem (PSTI) Ionis (IONS) Auspex (ASPX) CEMPRA (CEMP) GlaxoSmithKline (GSK) Alder Biopharmaceuticals (ALDR) IDERA (IDRA) JUNO (JUNO) Sanofi (SNY) Anacor (ANAC) Roche (ROCHE) Intrexon (XON) Ocular Therapeutix (OCUL) Global Cell Therapeutics (GBT) OncoCyte (OCX) KITE (KITE) JOUNCE THERAPEUTICS (JNCE) SYNTA (SNTA) REGULUS (RGLS) Inovio (INO) Ridaforolimus Vitae Pharmaceuticals (VTAE) Human Longevity (HLI) Dynavax (DVAX) Roche (RHHBY) Vertex (VRTX) INNOVIVA (INVA) SUNESIS PHARMACEUTICALS (SNSS) Zerenex AERIE PHARMACEUTICALS Elan (ELN) Velcade (bortezomib) Merck (MRK) Bellicum (BLCM) Tysabri Ziofpharm (ZIOP) Adaptimmune (ADAP) PORTOLA (PTLA) Xoma (XOMA) Agenus (AGEN) Biogen Idec (BIIB) RenenxBio (RGNX) Regeneron (REGN) Prolor Biotech (PBTH) KERYX (KERX) Abbott Laboratories (ABT) Theravance (THRX) Agenus (AGEN ISIS (ISIS)